Evidence map›Paper›PMID 30166857›Full record

ReviewWorld journal of gastroenterology2018

Kazuya Okushin, Takeya Tsutsumi, Kazuhiko Ikeuchi, Akira Kado, Kenichiro Enooku, Hidetaka Fujinaga, Kyoji Moriya, Hiroshi Yotsuyanagi, Kazuhiko Koike

Open access · bronzeAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Ultra-Micro Powder From Edible Plants (Food science & nutrition · 2026
    Article
  7. Frontiers in cellular and infection microbiology · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Effects and mechanisms ofWorld journal of gastroenterology · 2024
    Review
  13. Clinical Medicine Insights. Oncology · 2024
    Review
  14. Novel therapeutic regimens againstFrontiers in microbiology · 2024
    Review
  15. The Interplay betweenInternational journal of molecular sciences · 2023
    Review
  16. Review
  17. Article
  18. Article
  19. The Effects ofBioMed research international · 2023
    Article
  20. Frontiers in cellular and infection microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Kazuya OkushinDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
Takeya TsutsumiDivision of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan. tsutsumi@ims.u-tokyo.ac.jp.
Kazuhiko IkeuchiDepartment of Infectious Diseases, The University of Tokyo, Tokyo 113-8655, Japan.
Akira KadoDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
Kenichiro EnookuDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
Hidetaka FujinagaDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
Kyoji MoriyaDepartment of Infection Control and Prevention, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
Hiroshi YotsuyanagiDivision of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Kazuhiko KoikeDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
University Gastroenterology · USThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Both

Indexed as

Anti-Bacterial AgentsCarcinogenesisCarcinoma, HepatocellularDisease ProgressionHelicobacter InfectionsHelicobacter pyloriHepacivirusHepatitis C, ChronicHumansLiverLiver CirrhosisLiver NeoplasmsNon-alcoholic Fatty Liver DiseasePrevalenceRisk FactorsTreatment OutcomeAnti-Bacterial AgentsHelicobacter pyloriHepatitis B virusHepatitis C virusHepatocellular carcinomaNonalcoholic fatty liver diseaseNonalcoholic steatohepatitisViral hepatitis

Identifiers

PMID30166857
PMCPMC6113725
OpenAlexW2888863759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.